image
Enanta Pharmaceuticals, Inc. ENTA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.53
-5.92 %
$ 202 M
Market Cap
-1.75
P/E
INCOME STATEMENT
79.2 M REVENUE
-8.07%
Growth Rates
1Year -8.07%
3Years -13.52%
5Years -17.45%
7Years -1.54%
10Years 9.47%
-137 M OPERATING INCOME
-10.79%
Growth Rates
1Year -10.79%
3Years -48.81%
5Years -20.62%
7Years -27.40%
10Years -32.11%
-134 M NET INCOME
-9.91%
Growth Rates
1Year -9.91%
3Years -54.67%
5Years -23.39%
7Years -32.52%
10Years -31.01%
EFFICIENCY
Earnings Waterfall Enanta Pharmaceuticals, Inc.
image
Revenue 79.2 M
Cost Of Revenue 0
Gross Profit 79.2 M
Operating Expenses 216 M
Operating Income -137 M
Other Expenses -3.39 M
Net Income -134 M

Income Statement

Millions
Sep-2023 Sep-2022 Sep-2021 Sep-2020 Sep-2019 Sep-2018 Sep-2017 Sep-2016 Sep-2015 Sep-2014 Sep-2013 Sep-2012 Sep-2011 Sep-2010
REVENUE
Revenue 79.2 86.2 97.1 122.5 205.2 206.6 102.8 88.3 160.9 47.7 32.1 41.7 41.9 22.8
GROSS PROFIT
Cost Of Revenue 0 3.0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 79.2 83.2 97.1 122.5 205.2 206.6 102.8 88.3 160.9 47.7 32.1 41.7 41.9 22.8
OPERATING INCOME
Operating Expenses 216.4 210.0 206.6 164.1 168.5 118.3 78.2 57.4 36.7 28.8 23.0 20.4 16.6 15.8
Selling, General and Administrative Expenses 52.9 45.5 32.5 27.4 26.2 23.4 20.7 17.0 13.5 10.0 6.2 5.3 5.0 6.1
Research and Development Expenses 163.5 164.5 174.1 136.8 142.2 94.9 57.5 40.5 23.2 18.7 16.8 15.1 11.5 9.7
Operating Income (137.2) (123.8) (109.6) (41.6) 36.7 88.3 24.6 30.8 124.1 19.0 9.0 21.3 25.3 6.9
PRE-TAX INCOME
Interest Income Expense 5.1 1.6 0 0 8.8 4.9 40 K 45 K 8 K 18 K 31 K 0 3.2 0
Total Other Income 6.2 1.7 2.0 6.6 8.8 4.8 2.3 1.7 1.3 0.3 0.6 0.1 (2.0) 0.8
Pre-Tax Income (131.0) (122.2) (107.6) (35.0) 45.6 93.1 26.9 32.6 125.5 19.3 9.6 21.4 23.3 7.7
NET INCOME
Tax Provision 2.8 (0.4) (28.6) 1.1 (0.8) 21.2 9.2 10.9 46.5 (15.2) (0.2) 0 3.2 (0.2)
Net Income (133.8) (121.8) (79.0) (36.2) 46.4 72.0 17.7 21.7 79.0 34.4 9.6 21.4 23.3 7.9
EPS 6.38 5.91 3.92 1.81 2.37 3.48 0.93 1.14 4.23 1.88 0.67 1.18 1.35 0.0169